Socioeconomic Differences in Alcohol Harm in Finland in a Nationwide Cohort Study

Sponsor
Finnish Institute for Health and Welfare (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05865847
Collaborator
Social Insurance Institution, Finland (Other)
3,950,000
104.9

Study Details

Study Description

Brief Summary

This is a nationwide cohort study of Finnish adults aged 25 and older, who are followed up for the incidence of an alcohol-attributable hospitalization or death. The primary objective is to examine the relative and absolute socioeconomic differences in cause-specific alcohol-attributable hospital admissions and deaths.

Condition or Disease Intervention/Treatment Phase
  • Other: Not applicable, this is an observational study

Detailed Description

Background

Alcohol consumption is a leading risk factor for death and disability, resulting in substantial societal costs and social and community harm. Alcohol-related harm has been consistently shown to be higher among people of lower socioeconomic status, despite the fact they often report similar or lower levels of alcohol use. This apparent contrast has been called the alcohol harm paradox.

Understanding what explains the alcohol harm paradox is crucial for the design and implementation of population health interventions to reduce socioeconomic differences in alcohol harm. Explanations for the paradox can be broadly categorised into three groups: (i) differential exposure to alcohol, drinking patterns and trajectories and to other behavioural risk factors and joint effects among them, (ii) differential vulnerability resulting from individual factors, such as biological characteristics, psychological traits or stress, cumulative disadvantage and broader community and societal upstream factors, and (iii) differential biases in the measurement of alcohol exposure.

A crucial weakness of existing empirical studies comes from the operationalization of alcohol harm. With few exceptions, a vast majority of studies has used a composite endpoint combining several causes of alcohol-attributable deaths or hospitalizations or even merging alcohol-attributable hospital admissions with deaths in a single outcome. While this strategy increases the statistical power to analyse rare events, composite endpoints are prone to misclassification bias by masking divergent underlying patterns and associations.

Cause-specific analyses might shed light on different mechanisms driving the socioeconomic differences in overall alcohol-attributable harm, as well as opening potential avenues for policy interventions to reduce them. The study will take advantage of a recently formed dataset covering the total Finnish population to explore associations between socioeconomic status and cause-specific alcohol-attributable events. An additional contribution to the literature will be reporting both relative and absolute inequalities in alcohol-attributable harm. Absolute differences have been rarely reported even though might be as relevant as relative differences because, from a pragmatic standpoint, they are more feasible to reduce.

The study will aim to (1) examine the relative and absolute socioeconomic differences in cause-specific alcohol-attributable hospital admissions and deaths; (2) describe the geographical differences in cause-specific alcohol-attributable hospital admissions and deaths; and (3) quantify the relative contribution of each specific alcohol-attributable cause to the overall alcohol-attributable harm.

Study Design

Study Type:
Observational
Anticipated Enrollment :
3950000 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Unveiling the Alcohol Harm Paradox: Analysis of Socioeconomic Differences in Alcohol Harm in Finland in a Nationwide Cohort Study
Actual Study Start Date :
Jan 1, 2015
Actual Primary Completion Date :
Feb 28, 2020
Anticipated Study Completion Date :
Sep 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Lowest income groups

Deciles of equivalized net household income. The method compares the whole socioeconomic distribution.

Other: Not applicable, this is an observational study
Not applicable, this is an observational study

Outcome Measures

Primary Outcome Measures

  1. Alcohol intoxication - Hospitalization [January 1, 2016 to February 28, 2020]

    Incidence of alcohol intoxication hospitalization (ICD-10 F10.0-1)

  2. Alcohol intoxication - Death [January 1, 2016 to February 28, 2020]

    Death due to alcohol intoxication (ICD-10 F10.0-1)

  3. Alcohol dependence - Hospitalization [January 1, 2016 to February 28, 2020]

    Incidence of hospitalization due to alcohol dependence (F10.2)

  4. Alcohol dependence - Death [January 1, 2016 to February 28, 2020]

    Death due to alcohol dependence (F10.2)

  5. Psycho-organic syndrome caused by alcohol - Hospitalization [January 1, 2016 to February 28, 2020]

    Incidence of hospitalization due to psycho-organic syndrome caused by alcohol (F10.3-9)

  6. Psycho-organic syndrome caused by alcohol - Death [January 1, 2016 to February 28, 2020]

    Death due to psycho-organic syndrome caused by alcohol (F10.3-9)

  7. Alcoholic liver disease - Hospitalization [January 1, 2016 to February 28, 2020]

    Incidence of hospitalization due to alcoholic liver disease(K70)

  8. Alcoholic liver disease - Death [January 1, 2016 to February 28, 2020]

    Death due to alcoholic liver disease(K70)

  9. Pancreatic diseases caused by alcohol - Hospitalization [January 1, 2016 to February 28, 2020]

    Incidence of hospitalization due to pancreatic diseases caused by alcohol (K85.2, K86.0)

  10. Pancreatic diseases caused by alcohol - Death [January 1, 2016 to February 28, 2020]

    Death due to pancreatic diseases caused by alcohol (K85.2, K86.0)

  11. Gastritis caused by alcohol - Hospitalization [January 1, 2016 to February 28, 2020]

    Incidence of hospitalization due to gastritis caused by alcohol (K29.2)

  12. Gastritis caused by alcohol - Death [January 1, 2016 to February 28, 2020]

    Death due to gastritis caused by alcohol (K29.2)

  13. Alcoholic cardiomyopathy - Hospitalization [January 1, 2016 to February 28, 2020]

    Incidence of hospitalization due to alcoholic cardiomyopathy (I42.6)

  14. Alcoholic cardiomyopathy - Death [January 1, 2016 to February 28, 2020]

    Death due to alcoholic cardiomyopathy (I42.6)

  15. Nervous system disorders caused by alcohol - Hospitalization [January 1, 2016 to February 28, 2020]

    Incidence of hospitalization due to degeneration of the nervous system due to alcohol, epileptic seizures related to alcohol, alcoholic polyneuropathy, alcoholic myopathy (G312, G4051, G621, G721)

  16. Nervous system disorders caused by alcohol - Death [January 1, 2016 to February 28, 2020]

    Death due to degeneration of the nervous system due to alcohol, epileptic seizures related to alcohol, alcoholic polyneuropathy, alcoholic myopathy (G312, G4051, G621, G721)

  17. Alcohol poisoning - Hospitalization [January 1, 2016 to February 28, 2020]

    Incidence of hospitalization due to alcohol poisoning (T51, X45)

  18. Alcohol poisoning - Death [January 1, 2016 to February 28, 2020]

    Death due to alcohol poisoning (T51, X45)

Eligibility Criteria

Criteria

Ages Eligible for Study:
25 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Permanent residents (defined by Statistics Finland as those Finnish and foreign nationals who have a legal domicile in Finland and intend to stay (or have stayed) for at least one year) alive in Finland by December 31, 2015

  • Age 25 years or older by January 1, 2016

  • Not having an alcohol-attributable hospitalization during the past three years ((January 2013-December 2015

Exclusion Criteria:
  • Temporary residents, including foreign nationals living in Finland for less than a year, asylum seekers who have not been granted a legal domicile, temporary migrant workers and Finnish nationals living temporarily abroad by December 31, 2015

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Finnish Institute for Health and Welfare
  • Social Insurance Institution, Finland

Investigators

  • Principal Investigator: Sebastián Peña, MD, PhD, Finnish Institute for Health and Welfare
  • Study Chair: Sonja Lumme, PhD, Finnish Institute for Health and Welfare
  • Study Chair: Päivikki Koponen, PhD, Finnish Institute for Health and Welfare

Study Documents (Full-Text)

More Information

Additional Information:

Publications

Responsible Party:
Finnish Institute for Health and Welfare
ClinicalTrials.gov Identifier:
NCT05865847
Other Study ID Numbers:
  • KKO-Inv 4-Johto-VPT-Terveysind
First Posted:
May 19, 2023
Last Update Posted:
May 19, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 19, 2023